Filing Flows

Filing Flows › Companies › Lunai Bioworks › Cash flow

Lunai Bioworks cash flow, quarter by quarter

Latest: Q4 FY26 · from the cash-flow statements filed with the SEC

Free cash flow−$1.8M in Q4 FY26

Operating cash flow−$1.8M
Free cash flow−$1.8M

Analysis

In Q4 FY26, Lunai Bioworks generated −$1.8M of operating cash flow. That is $30K less than in Q4 FY25 (−$1.8M).

Operating cash flow was −$1.8M against net income of −$2.0M. The largest differences: payables −$286K, prepaid and other assets +$162K, stock-based pay +$151K.

Free cash flow

Lunai Bioworks: free cash flow by quarterLunai Bioworks: free cash flow by quarter−$2.0MQ1 FY25−$2.6MQ2 FY25−$1.5MQ3 FY25−$1.8MQ4 FY25−$1.3MQ1 FY26−$1.1MQ2 FY26−$1.0MQ3 FY26−$1.8MQ4 FY26
Operating cash flow less capital spending.
Lunai Bioworks: operating cash flow against capital spendingLunai Bioworks: operating cash flow against capital spendingOperating cash flowCapital spending−$2.0M$0Q1 FY25−$2.6M$0Q2 FY25−$1.5M$0Q3 FY25−$1.8M$0Q4 FY25−$1.3M$0Q1 FY26−$1.1M$0Q2 FY26−$1.0M$0Q3 FY26−$1.8M$0Q4 FY26
Latest (Q4 FY26): Operating cash flow −$1.8M, Capital spending $0.

Capital allocation, year by year

Lunai Bioworks: where the cash came from (up) and went (down), by fiscal yearLunai Bioworks: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY22: Operating cash flow −$15.7MFY22: Shares issued $5KFY22: Capital spending −$5K$5KFY22FY23: Operating cash flow −$11.8MFY23: Capital spending −$30KFY23FY24: Operating cash flow −$11.0MFY24: Net borrowing $3.8MFY24: Capital spending −$70K$3.8MFY24FY25: Operating cash flow −$7.9MFY25: Shares issued $185K$185KFY25FY26: Operating cash flow −$5.3MFY26: Net borrowing $7.4MFY26: Capital spending −$1K$7.4MFY26
Over these 5 years operating cash flow totalled −$51.6M; the largest uses were operating cash flow ($51.6M) and capital spending ($107K). Cash-flow statements as filed.

Where the cash came from and went

Lunai Bioworks: sources (+) and uses (−) of cash, Q4 FY26Lunai Bioworks: sources (+) and uses (−) of cash, Q4 FY26Operating cash flow−$1.8MCash drawn (+) / kept (−)$1.4MOther financing$395KExchange rates$5K

From profit to cash

Lunai Bioworks: net income to operating cash flow, Q4 FY26Lunai Bioworks: net income to operating cash flow, Q4 FY26Net income−$2.0MDepreciation & amortization$30KStock-based pay$151KReceivables$125KPayables−$286KAccrued liabilities$107KPrepaid and other assets$162KOther liabilities−$32KOperating cash flow−$1.8M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q4 FY26−$1.8M—$1.4M−$1.8M
Q3 FY26−$1.0M$508K−$2.7M−$1.0M
Q2 FY26−$1.1M$200K$133K−$1.1M
Q1 FY26−$1.3M$1.6M−$532K−$1.3M
Q4 FY25−$1.8M—$830K−$1.8M
Q3 FY25−$1.5M$856K−$611K−$1.5M
Q2 FY25−$2.6M$2.5M−$91K−$2.6M
Q1 FY25−$2.0M—−$104−$2.0M

Lunai Bioworks: income statement and cash flow

Lunai Bioworks, Q4 FY26: revenue $31K. The chart follows the revenue to costs, profit and cash.

Lunai Bioworks: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.